Home LiteratureArticle Details
PMID: 6972383 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Journal of clinical microbiology ·Vol. 13 ·No. 3 ·1981-03-00 ·Pages 532-9

Kaplan SL, Umstead CL, Mason EO, Anderson DC, Parke JC, Feigin RD

Abstract

A luminol-enhancement chemiluminescence assay and a radiolabeled uptake assay were developed to assess opsonins for Haemophilus influenzae type b. Opsonins in acute and convalescent sera from 17 children with H. influenzae type b meningitis, along with pooled normal human sera, were evaluated and compared with anti-polyribosephosphate antibody concentrations. Five children had a rise in the chemiluminescence-area under the curve for convalescent compared with acute sera. Patient chemiluminescence--area-under-the-curve values were significantly (P less than 0.05) more likely to exceed 50% of normal human serum values if sera contained greater than or equal to 0.1 microgram of anti-polyribosephosphate antibody per ml. Magnesium ethylene glycol tetraacetic acid chelation and heat inactivation of patient and normal human sera significantly (P less than 0.05) reduced chemiluminescence--area-under-the-curve activity. Thus, complement appears to contribute significantly to the opsonization of H. influenzae type b in sera of children. Two of nine children had increases in opsonins as assayed by 3H-labeled H. influenzae type b uptake. After natural systemic H. influenzae type b infection, young children are unable to respond acutely with an increase in anti-polyribosephosphate antibody or serum opsonic activity.

MeSH Terms
Antibodies, Bacterial/analysis Biological Assay Child, Preschool Haemophilus influenzae/classification,immunology Humans Infant Luminescent Measurements Meningitis, Haemophilus/immunology Neutrophils/physiology Opsonin Proteins/analysis Polysaccharides, Bacterial/immunology
Chemicals
Antibodies, Bacterial Opsonin Proteins Polysaccharides, Bacterial
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kaplan S L
Umstead C L
Mason E O
Anderson D C
Parke J C
Feigin R D
References (18)
18 references, click to expand
  1. Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity.
    Infect Immun. 1978 Aug;21(2):619-26 PMID: 80382
  2. Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model.
    Infect Immun. 1978 Jun;20(3):705-13 PMID: 307539
  3. The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers.
    Pediatrics. 1979 Mar;63(3):429-34 PMID: 375175
  4. Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.
    Infect Immun. 1979 Oct;26(1):99-109 PMID: 387613
  5. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.
    J Infect Dis. 1980 Mar;141(3):370-81 PMID: 6988524
  6. Human serum activities against Hemophilus influenzae, type b.
    J Clin Invest. 1972 Jan;51(1):31-8 PMID: 4536614
  7. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
    J Clin Invest. 1972 Jan;51(1):39-44 PMID: 4536615
  8. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.
    Pediatr Res. 1973 Mar;7(3):103-10 PMID: 4120458
  9. Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.
    Infect Immun. 1973 Sep;8(3):488-90 PMID: 4542337
  10. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Pediatrics. 1973 Nov;52(5):637-44 PMID: 4542777
  11. Typing of Haemophilus influenzae by counterimmunoelectrophoresis.
    Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Apr;82(2):164-6 PMID: 4137338
  12. Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.
    J Clin Invest. 1975 Oct;56(4):1012-22 PMID: 1099117
  13. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.
    Infect Immun. 1976 Oct;14(4):882-7 PMID: 1086832
  14. Serologic responses of children with meningitis due to Haemophilus influenzae type b.
    J Infect Dis. 1976 Nov;134(5):495-9 PMID: 1086875
  15. Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.
    Infect Immun. 1977 Mar;15(3):828-33 PMID: 323143
  16. Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.
    Infect Immun. 1977 Jun;16(3):796-804 PMID: 70407
  17. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Pediatrics. 1977 Nov;60(5):730-7 PMID: 335348
  18. In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.
    Infect Immun. 1978 Oct;22(1):41-51 PMID: 215546
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1981-03-00
Pages
532-9
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC273827
Subset
IM
Grants
NINDS NIH HHS · R01NS14292-03/04 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]